Risk of Cardiac Conduction Disorders Among Individuals Tested for Serum Borrelia burgdorferi Antibodies

Clinical Microbiology and Infection (Tetens, M. M., et al.) 02.02.2024 published, “Risk of cardiac conduction disorders, and pacemaker implantations among individuals tested for serum Borrelia burgdorferi antibodies, a nationwide, matched, population-based cohort study.” The study aimed to investigate the short and long-term risks of atrioventricular block (a cardiac conduction disorder) and other cardiac conduction disorders associated with testing for Borrelia burgdorferi antibodies or Borrelia burgdorferi seropositivity.

The results of the study indicated that individuals tested for Borrelia burgdorferi antibodies had increased short and long-term risks of atrioventricular block and other conduction disorders compared to population controls. The study suggests that Bb antibody testing should be considered in the diagnostic work-up of conduction disorders, particularly atrioventricular block. 


For More Information: 

Read the article on the Clinical Microbiology and Infections website here.

Read more on Cardiac Lyme on LDA’s website here.

Read a case study on Lyme Carditis on LDA’s website here.